The shroud of secrecy that veils the drug supply chain can make it challenging even for experienced health care professionals.
On the recordMay 20, 2019
Source
congress.govEditor's note · Context
Engel discusses the difficulties in understanding drug costs due to lack of transparency.
Share
More from Eliot Engel
Dec 7, 2020
H. Res. 189 is a very important resolution. I support it and encourage my colleagues to do so as well. I think that both sides of the aisle understand how important this is, and it is good to see us working together. Mr. Speaker, I yield…
Nov 18, 2020
I once again thank Mr. Jeffries for authoring this important legislation. Mr. Speaker, I urge my colleagues on both sides of the aisle to support this legislation, and I yield back the balance of my time. The SPEAKER pro tempore. The…
Dec 8, 2020
Why have there been no designations by us of Russian companies and individuals who are so clearly and shamelessly giving Assad a lifeline?





